Andrius Žučenka: Congratulations to All the Investigators Involved in the PARADIGM trial
Andrius Žučenka, Assistant professor at Vilniaus universitetas / Vilnius University, shared a post on LinkedIn:
“First and foremost, huge congratulations to all the investigators and everyone involved in the Paradigm trial, the hottest acute myeloid leukemia (AML) topic at the American Society of Hematology 2025. King 7+3 took a massive blow. But has lord HMA+Ven truly won?
Before reading further I sincerely recommend listening to the most recent Wolverheme podcast.
Bernard Marini and Anthony Perissinotti superbly analyzed the presented abstract in such great detail, that there’s no point for me to go through specific trial data here, (KUDOS, guys). I want to simply present my few thoughts from a general/our center’s perspective.”
Read full paper here.
Get the latest updates on Hemostasis Today.
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award
-
Sep 24, 2026, 18:42Titilope Fasipe: Proud to Support American Society of Hematology’s SCD Initiative
-
Sep 24, 2026, 18:34Ifeanyichukwu Ifechidere: Why Coagulation Samples Can Be “Too Valuable to Throw Away”?
-
Sep 24, 2026, 18:33Aswin K. Mohan: When a Superpower Hears the Call for Blood
-
Sep 24, 2026, 18:31Mercy Lung’aho: Anemia Is Not Only An Iron Problem
-
Sep 24, 2026, 18:29Nick Hanson: Before a Dementia Diagnosis Check Vitamin B12
-
Sep 24, 2026, 18:28Rachel McBryan: Nearly One in Five Older Canadians Has Low Vitamin B12
-
Sep 24, 2026, 18:27Kemal Karaagac: Early DOAC Initiation After Acute Ischaemic Stroke in Atrial Fibrillation
-
Sep 24, 2026, 18:26Mohammed A. AlOmar: What Characterizes Young Stroke in the UAE?